Mark Hallett is an American neurologist who researched the physiology of human movement and movement disorders including functional motor disorders at the NIH, and currently serves as Distinguished NIH Investigator Emeritus.[1][2][3] Hallett worked at NIH for 40 years in the federal government, with several decades at the Human Motor Control Section and was previously chief of the Clinical Neurophysiology Laboratory at Brigham Women's Hospital.[1]
Mark Hallett | |
|---|---|
| Born | 1943 |
| Alma mater | Harvard |
| Known for | Physiology of motor control and movement disorders |
| Scientific career | |
| Institutions | NIH Intramural Research Program |
| Doctoral advisor | C. David Marsden |
| Notable students | Alvaro Pascual-Leone |
Research
editHallett has contributed work "to the principles of normal human voluntary movement, understanding the motor system and movement disorders including dystonia, parkinsonism and myoclonus, and the use of transcranial magnetic stimulation (TMS) and botulinum toxin to treat movement disorders."[1] He is noted for his prolific research output throughout his career and is the 96th most cited scientist in the United States, according to Research.com, by h-index.[1] Hallett has suggested that education, awareness, and availability of the latest treatment programs remains a key challenge for motor diseases.[3] His work is considered to be pioneering in the field of functional motor disorders.[4]
Hallett is also considered a pioneer of the field of TMS and helped create the first conferences on TMS safety guidelines, as well as providing additional foundational research around principles of brain stimulation; he was awarded the 2019 International Brain Stimulation Award as a result.[5]
Career
editHallett graduated from Harvard with an AB and MD and trained at Peter Bent Brigham hospital and Massachusetts General Hospital.[2] Hallett also founded the Functional Neurological Disorder Society in 2003 and served as an editor in chief of Clinical Neurophysiology.[6][2] He has also served as President of the International Parkinson and Movement Disorder Society and Vice-President of the American Academy of Neurology.[2] He retired from NIH and serves as professor emeritus as of 2023 after 40 years of federal service.[1] Hallett pioneered experimental botulinum injections to treat Leon Fleisher's hand dystonia.[7] In the wake of diplomats suffering Havana Syndrome, Hallett was among the physicians asked to examine the diplomats.[4]
Neurophysiology of free will
editHallett has worked on topics of volition and free will through a neurophysiological lens, including reformulations of the Libet clock experiment.[8][9]
References
edit- ^ a b c d e Garnett, Shannon E. (2023-01-06). "NINDS's Hallett Retires After 40 Years of Federal Service". NIH Record. Retrieved 2024-01-20.
- ^ a b c d "Mark Hallett, M.D. | NINDS Division of Intramural Research". research.ninds.nih.gov. Retrieved 2024-01-22.
- ^ a b Hurley, Dan (2023-01-19). "Mark Hallett, MD, Leader in Study of Functional Neurological Disorders, On Future Challenges of the Field". Neurology Today. 23 (2): 17–18. doi:10.1097/01.NT.0000919252.05650.5a. ISSN 1533-7006. S2CID 256189302.
- ^ a b Hurley, Dan (2019-05-15). "Was It an Invisible Attack on U.S. Diplomats, or Something Stranger?". The New York Times. ISSN 0362-4331. Retrieved 2024-01-22.
- ^ Spieler, Josh. "2019 International Brain Stimulation Award winner announced". EurekAlert!. Retrieved 2024-02-13.
- ^ Romeo, Michael. "Mark Hallett: Celebrating 40 Years of Service and Pioneering Work in Neuroscience" (PDF). Functional Neurological Disorder Society.
- ^ "Human Motor Control | NIH Intramural Research Program". irp.nih.gov. Retrieved 2024-01-24.
- ^ "Mark Hallett, M.D., D.M.(hon) – Neurophilosophy of Free Will". neurophil-freewill.org. Retrieved 2024-01-22.
- ^ Matsuhashi, Masao; Hallett, Mark (December 2008). "The timing of the conscious intention to move". The European Journal of Neuroscience. 28 (11): 2344–2351. doi:10.1111/j.1460-9568.2008.06525.x. ISSN 1460-9568. PMC 4747633. PMID 19046374.